PTEN regulates phospholipase D and phospholipase C
Christopher A Alvarez-Breckenridge1, Kristin A Waite, Charis Eng
1Department of Evolution, Ecology and Organismal Biology, The Ohio State University, Columbus, OH 43210, USA.
Human Molecular Genetics
|April 5, 2007
Summary
PTEN, a tumor suppressor, regulates lipid signaling beyond the PI3K/AKT pathway. This finding reveals new therapeutic targets for Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS) related cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- PTEN is a crucial tumor suppressor involved in various cancers.
- Germline PTEN mutations are linked to Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS).
- PTEN's tumor suppressor role is traditionally attributed to inhibiting the PI3K/AKT pathway via its lipid phosphatase activity.
Purpose of the Study:
- To investigate PTEN's role in lipid signaling and homeostasis beyond the PI3K/AKT pathway.
- To explore PTEN's regulation of phospholipase D (PLD) and phospholipase C (PLC) pathways.
- To understand the complex biochemical basis of CS/BRRS pathogenesis.
Main Methods:
- Overexpression of PTEN in MCF-7 breast cancer cells.
- Measurement of phosphatidic acid and phosphatidylcholine levels.
- Assay of basal phospholipase D (PLD) activity.
- Investigation of PTEN's effect on phospholipase C (PLC) activation.
Main Results:
- Increased PTEN expression led to higher phosphatidic acid and lower phosphatidylcholine levels.
- PTEN overexpression significantly increased basal PLD activity.
- Data suggest PTEN modulates PLC and PLD activation pathways.
Conclusions:
- PTEN's tumor suppressor function extends to regulating lipid signaling pathways, including PLD and PLC.
- The pathogenesis of CS/BRRS involves complex biochemical mechanisms beyond PI3K/AKT pathway inhibition.
- These findings offer novel therapeutic targets for cancer therapy and prevention.
Related Concept Videos
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...